ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 129 filers reported holding ANIKA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,130,061 | -36.6% | 114,335 | -11.6% | 0.00% | -50.0% |
| Q2 2023 | $3,359,291 | -9.5% | 129,303 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,713,582 | +10.4% | 129,303 | +13.8% | 0.00% | 0.0% |
| Q4 2022 | $3,364,159 | +24.4% | 113,654 | +0.0% | 0.00% | +100.0% |
| Q3 2022 | $2,704,000 | +57.6% | 113,613 | +47.8% | 0.00% | 0.0% |
| Q2 2022 | $1,716,000 | -13.8% | 76,862 | -3.1% | 0.00% | 0.0% |
| Q1 2022 | $1,991,000 | -14.4% | 79,312 | +22.2% | 0.00% | 0.0% |
| Q4 2021 | $2,325,000 | +15.3% | 64,892 | +36.9% | 0.00% | 0.0% |
| Q3 2021 | $2,017,000 | -1.7% | 47,392 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,052,000 | +6.2% | 47,392 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,933,000 | +15.4% | 47,392 | +28.1% | 0.00% | 0.0% |
| Q4 2020 | $1,675,000 | +27.9% | 37,000 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $1,310,000 | -2.6% | 37,021 | +0.1% | 0.00% | 0.0% |
| Q2 2020 | $1,345,000 | – | 37,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |